pyranoprofen has been researched along with Anasarca in 6 studies
pyranoprofen: RN given refers to unlabled parent cpd; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "5mg/mL, PF-F2NPs with cPF 1mg/mL) produced by solvent displacement technique and tested the in vitro cytotoxicity, ex vivo corneal permeation, in vivo ocular tolerance and in vivo anti-inflammatory efficacy of PF-F1NPs, PF-F2NPs, in comparison to eye drops conventional dosage form (Oftalar(®), PF 1mg/mL) and free drug solution (PF dissolved in PBS, 1." | 1.43 | In vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration. ( Abrego, G; Alvarado, H; Calpena, AC; Cañadas, C; García, ML; Silva, AM; Souto, EB, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, IJ | 1 |
| Lee, CW | 1 |
| Lee, MY | 1 |
| Kang, MR | 1 |
| Yun, J | 1 |
| Oh, SJ | 1 |
| Han, SB | 1 |
| Lee, K | 1 |
| Park, SK | 1 |
| Kim, HM | 1 |
| Jung, SH | 1 |
| Kang, JS | 1 |
| Abrego, G | 2 |
| Alvarado, H | 2 |
| Souto, EB | 2 |
| Guevara, B | 1 |
| Bellowa, LH | 1 |
| Garduño, ML | 1 |
| Garcia, ML | 2 |
| Calpena, AC | 2 |
| Cañadas, C | 1 |
| Silva, AM | 1 |
| Tsurumi, K | 2 |
| Kyuki, K | 1 |
| Niwa, M | 1 |
| Kokuba, S | 2 |
| Fujimura, H | 2 |
| Okada, K | 1 |
| Yanagihara, M | 1 |
| Terasawa, M | 1 |
| Imayoshi, T | 1 |
| Iwahisa, Y | 1 |
| Maruyama, Y | 1 |
6 other studies available for pyranoprofen and Anasarca
| Article | Year |
|---|---|
Differential anti-inflammatory and analgesic effects by enantiomers of zaltoprofen in rodents.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzopyrans; Disease Mod | 2013 |
Biopharmaceutical profile of hydrogels containing pranoprofen-loaded PLGA nanoparticles for skin administration: In vitro, ex vivo and in vivo characterization.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzopyrans; Drug Carriers; Drug Liberation | 2016 |
In vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration.
Topics: Administration, Ophthalmic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzopyrans; Cell Surv | 2016 |
Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid. 1st communication: inhibitory effects of rat paw edema.
Topics: Adrenalectomy; Animals; Anti-Inflammatory Agents; Benzopyrans; Benzothiepins; Edema; Indomethacin; M | 1986 |
Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl]propionic acid. 4th communication: inhibitory effects on rat adjuvant arthritis.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Benzopyrans; Benzothiepins; B | 1986 |
[Anti-inflammatory effect of topically applied pranoprofen-gel].
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Benzopyrans; Capillary Permeability; Ede | 1985 |